Good Bug, Bad Bug: Breaking through Microbial Stereotypes

Cell Host and Microbe

Volumn 23, Issue 1, 2018, Pages 10-13

  Cirstea, Mihai ^a,b   Radisavljevic, Nina ^a,b   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; RNA 16S;

AKKERMANSIA MUCINIPHILA; AUTOIMMUNE DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CROHN DISEASE; DYSLIPIDEMIA; FECAL MICROBIOTA TRANSPLANTATION; HELICOBACTER PYLORI; HELMINTHIASIS; HUMAN; INFLAMMATORY DISEASE; INTESTINE FLORA; IRRITABLE COLON; METABOLIC DISORDER; NECATOR AMERICANUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PEPTIC ULCER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SALMONELLA; SHIGELLA; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VERRUCOMICROBIA;

DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; OBESITY; PROBIOTICS; VERRUCOMICROBIA;

EID: 85044714491     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.12.008     Document Type: Note

References (15)

1. Adeegbe, D.O., Nishikawa, H., Natural and induced T regulatory cells in cancer. Front. Immunol., 4, 2013, 190.
2. Amedei, A., Codolo, G., Del Prete, G., de Bernard, M., D'Elios, M.M., The effect of Helicobacter pylori on asthma and allergy. J. Asthma Allergy 3 (2010), 139–147.
3. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
4. Berer, K., Gerdes, L.A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S.E., et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. USA 114 (2017), 10719–10724.
5. Bernstein, C., Holubec, H., Bhattacharyya, A.K., Nguyen, H., Payne, C.M., Zaitlin, B., Bernstein, H., Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 85 (2011), 863–871.
6. Cekanaviciute, E., Yoo, B.B., Runia, T.F., Debelius, J.W., Singh, S., Nelson, C.A., Kanner, R., Bencosme, Y., Lee, Y.K., Hauser, S.L., et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl. Acad. Sci. USA 114 (2017), 10713–10718.
7. Denniston, E., Crewdson, H., Rucinsky, N., Stegman, A., Remenar, D., Moio, K., Clark, B., Higginbotham, A., Keffer, R., Brammer, S., Horzempa, J., The practical consideration of Poliovirus as an oncolytic virotherapy. Am. J. Virol. 5 (2016), 1–7.
8. Derrien, M., Belzer, C., de Vos, W.M., Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 106 (2017), 171–181.
9. Heintz-Buschart, A., Pandey, U., Wicke, T., Sixel-Döring, F., Janzen, A., Sittig-Wiegand, E., Trenkwalder, C., Oertel, W.H., Mollenhauer, B., Wilmes, P., The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Mov. Disord., 2017, 10.1002/mds.27105.
10. Hill-Burns, E.M., Debelius, J.W., Morton, J.T., Wissemann, W.T., Lewis, M.R., Wallen, Z.D., Peddada, S.D., Factor, S.A., Molho, E., Zabetian, C.P., et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32 (2017), 739–749.
11. Kelly, C.R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., Wu, G., Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149 (2015), 223–237.
12. Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23 (2017), 107–113.
13. Virgin, H.W., The virome in mammalian physiology and disease. Cell 157 (2014), 142–150.
14. Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C., Carlsson, C.M., Asthana, S., Zetterberg, H., Blennow, K., et al. Gut microbiome alterations in Alzheimer's disease. Sci. Rep., 7, 2017, 13537.
15. Wammes, L.J., Mpairwe, H., Elliott, A.M., Yazdanbakhsh, M., Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. Lancet Infect. Dis. 14 (2014), 1150–1162.